B Disorders of Autonomic Nervous System

Total Page:16

File Type:pdf, Size:1020Kb

B Disorders of Autonomic Nervous System Application of the International Classification of Diseases to Neurology \ Second Edition World Health Organization Geneva 1997 First edition 1987 Second edition 1997 Application of the international classification of diseases to neurology: ICD-NA- 2nd ed. 1. Neurology - classification 2. Nervous system diseases - classification I. Title: ICD-NA ISBN 92 4 154502 X (NLM Classification: WL 15) The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available. ©World Health Organization 1997 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. Typeset in Hong Kong Printed in Canada 95/10663-Best-set/Tri-Graphics-8000 Contents Preface v Acknowledgements vii Section I Introduction 1 Section II Instructions and recommendations for the use of ICD-NA 13 Section III List of block titles 19 Section IV Tabular list of neurological and related disorders 31 Section V Morphology of neoplasms 459 Index 477 Table of drugs and chemicals 565 iii Preface The Application of the International Classification of Diseases to Neurology (ICD-NA) is one of several adaptations of the Tenth Revision of the Interna­ tional Statistical Classification of Diseases and Related Health Problems (ICD-10) being produced by the World Health Organization to respond to the needs of specialist disciplines such as neurology. A previous edition of ICD-NA was developed in 1984-85 with the help of a group of experts convened by Dr L. Bolis (International Foundation Fatebenefratelli, Milan, Italy), then in charge of activities dealing with the prevention and control of neurological disorders in WHO's Division of Mental Health (MNH). Taking into account the recommendations of this expert group and advice received from the Neuroepidemiology Group of the World Federation of Neurology, chaired by the late Professor B.S. Schoenberg (National Institutes of Health, Bethesda, MD) and from other nongovernmental organizations, Professor J.-M. Orgogozo and Professor J.F. Dartigues (University of Bordeaux, France) drafted the text of the first edition in English and French. That edition provided an extensive selection, but a limited expansion, of the neurologically relevant codes of ICD-9. The present edition has been developed with the broader aim of providing an individual code for almost every neurological condition, so that a uniform classification is available for epidemiological and clinical research as well as for routine statistical reporting. The synopsis of the second edition of ICD-NA was produced by Professor W.G. Bradley (University of Miami, Miami, FL), Professor J.-M. Orgogozo, Dr N. Sartorius (then Director of WHO's Division of Mental Health) and Dr J. van Drimmelen (WHO, Geneva, Switzerland). It was discussed with repre­ sentatives of nongovernmental organizations active in the field of neurology and with experts in WHO and from various Member countries and then used as a framework for the development of the ICD-NA. The initial draft of ICD-NA was produced by Professors Bradley and Orgogozo with the help of Dr van Drimmelen on the basis of the first edition and of detailed suggestions from the Ad Hoc Committee on Disease Clas­ sification of the American Neurological Association, chaired by Professor Bradley; in the Acknowledgements section (pages ix-xii), the names of the members of the committee are marked with an asterisk. The draft was exam­ ined by nongovernmental organizations active in the field of neurology (listed on page xi) and by numerous advisers. Their valuable comments contributed v ICD-NA to the production of the penultimate version of ICD-NA, which was again reviewed by the participating nongovernmental organizations. The final version reflects the best resolution of many, often competing, needs. It should be kept in mind that ICD-NA had to be based upon the structure of ICD-10. This has prevented the introduction of some changes that were recommended, but has ensured that all of the 5-, 6- and ?-character codes of the ICD-NA can be contracted back into the original 3- or 4-character codes of ICD-10; compatibility with the official classification can therefore be main­ tained, whatever the purpose or level of utilization. The ICD-NA index was produced by Mr M. Catan and Dr van Drimmelen of WHO, using a preliminary partial draft produced by Drs H.J. Freyberger and C. Kessler (Liibeck, Germany), with extensive help from Mr A. L'Hours of WHO's Division of Health Situation and Trend Assessment. Guidance from Mr l'Hours also helped to ensure the congruence of ICD-NA with the parent ICD-10. An outline of the history of the International Classification of Diseases, infor­ mation on the structure of ICD-NA and instructions on its use are given in Sections I and II of this publication. Dr N.P. Napalkov Assistant Director-General World Health Organization vi Acknowledgements The following organizations provided invaluable support to the development of this publication: American Academy of Neurology American Neurological Association American Sleep Disorders Association European Federation of Neurological Societies European Stroke Council International Brain Research Organization International Bureau for Epilepsy International Cerebral Palsy Society International Child Neurology Association International Federation of Multiple Sclerosis Societies International Headache Society International League Against Epilepsy International Movement Disorder Society International Society of Neuropathology International Stroke Society World Federation for Mental Health World Federation of Neurology World Federation of Neurosurgical Societies Special thanks are due to Lord Walton of Detchant, whose continuing and strong support greatly facilitated the work on this publication, and to Professor Armand Lowenthal, of the World Federation of Neurology (WFN), who was particularly helpful in obtaining comments from Committees and Research Groups of the World Federation of Neurology. Administrative support for this work was provided by Ms J. Gilmore, Mrs J. Joseph and Mrs T. Drouillet. The work done by the following individuals, whose comments were particularly helpful and thoughtful, is gratefully acknowledged. Members of the Ad Hoc Committee on Neurological Classification of the American Neurological Association are indicated with an asterisk (*). *Dr R. Ackerman, Boston, MA, USA *Dr H. Adams, Glasgow, Scotland vii ICD-NA Dr Y. Agid, Paris, France Dr A. Ahmed, Karachi, Pakistan Dr L. Amaducci, Florence, Italy DrS. Araki, Kumamoto, Japan *Dr B. Amason, Chicago, IL, USA *Dr J. Bale, Iowa City, lA, USA *Dr B. Banker, Hanover, Germany Sir Roger Bannister, Oxford, England Dr B. Barac, Zagreb, Croatia Dr H. Barnett, London, Ontario, Canada *Dr R.W. Beck, Tampa, FL, USA *Dr W. Bell, Iowa City, lA, USA *Dr D.F. Benson, Los Angeles, CA, USA Dr A. Beraldelli, Rome, Italy *Dr J. Berger, Miami, FL, USA Dr N.E. Bharucha, Bombay, India Dr K.L. Bick, Washington, DC, USA Dr C.D. Binnie, London, England *Dr P. Black, Boston, MA, USA Dr J.P. Blass, New York, NY, USA *Dr J. Blavis, New York, NY, USA Dr J. Bogousslavsky, Lausanne, Switzerland *Dr W.G. Bradley, Miami, FL, USA *Dr B. Brookes, Madison, WI, USA *Dr J. Bruni, Mississauga, Ontario, Canada *Dr L. Caplan, Boston, MA, USA Dr P. Casaer, Louvain, Belgium Dr J.-P. Castel, Bordeaux, France *Dr M. Cohen, Buffalo, NY, USA *Dr M. Cole, Mayfield Heights, OH, USA *Dr P. Cooper, London, Ontario, Canada Dr R. Currier, Jackson, MS, USA *Dr D. Dalessio, La Jolla, CA, USA *Dr A. Damasio, Iowa City, lA, USA Dr J.P. Dartigues, Bordeaux, France *Dr J. Daube, Rochester, MN, USA Dr D .E. Deisenhammer, Vienna, Austria *Dr R. DeLorenzo, Richmond, VA, USA *Dr S. Diamond, Chicago, IL, USA *Dr R. Dorwart, Burlington, VT, USA *Dr D. Drachman, Worcester, MA, USA Dr C. Dravet, Marseilles, France *Dr F.E. Dreifuss, Charlottesville, VA, USA *Dr R. Duvoisin, New Brunswick, NJ, USA viii ACKNOWLEDGEMENTS *Dr P. Dyck, Rochester, MN, USA *Dr A.G. Engel, Rochester, MN, USA *Dr O.B. Evans, Jackson, MS, USA *DrS. Fahn, New York, NY, USA Dr N. Fejerman, Buenos Aires, Argentina *Dr R. Feldman, Boston, MA, USA *Dr G. Fenichel, Nashville, TN, USA *Dr P. Finelli, Providence, RI, USA *Dr R.A. Fishman, San Francisco, CA, USA Dr S. Flache, Geneva, Switzerland Dr D. Gardner-Medwin, Newcastle-upon-Tyne, England Dr C. Goetz, Chicago, IL, USA *Dr M. Gomez, Rochester, MN, USA *Dr B. Griggs, Rochester, MN, USA *Dr C. Gross, Burlington, VT, USA *Dr A. Harding, London, England Dr 0. Henriksen, Sandvika, Norway Dr P. Henry, Bordeaux, France Dr A. Huber, Zurich, Switzerland *Dr J.T. Hughes, Oxford, England *Dr C. J ablecki, San Diego, CA, USA Dr P. Jallon, Geneva, Switzerland Dr J. Jancovic, Houston, TX, USA *Dr P.J. Janetta, Pittsburgh, PA, USA Dr F.R. Jeri, Lima, Peru *Dr R.T. Johnson, Baltimore, MD, USA *Dr B. Katzman, La Jolla, CA, USA Dr J. Kesselring, Bad Ragaz, Switzerland *Dr A.
Recommended publications
  • 19-0603 ) Issued: January 28, 2020 DEPARTMENT of the TREASURY, ) INTERNAL REVENUE SERVICE, ) Holtsville, NY, Employer ) ______)
    United States Department of Labor Employees’ Compensation Appeals Board __________________________________________ ) S.L., Appellant ) ) and ) Docket No. 19-0603 ) Issued: January 28, 2020 DEPARTMENT OF THE TREASURY, ) INTERNAL REVENUE SERVICE, ) Holtsville, NY, Employer ) __________________________________________ ) Appearances: Case Submitted on the Record Thomas S. Harkins, Esq., for the appellant1 Office of Solicitor, for the Director DECISION AND ORDER Before: CHRISTOPHER J. GODFREY, Chief Judge ALEC J. KOROMILAS, Alternate Judge VALERIE D. EVANS-HARRELL, Alternate Judge JURISDICTION On January 18, 2019 appellant, through counsel, filed a timely appeal from a July 26, 2018 merit decision of the Office of Workers’ Compensation Programs (OWCP). Pursuant to the Federal Employees’ Compensation Act2 (FECA) and 20 C.F.R. §§ 501.2(c) and 501.3, the Board has jurisdiction over the merits of this case.3 1 In all cases in which a representative has been authorized in a matter before the Board, no claim for a fee for legal or other service performed on appeal before the Board is valid unless approved by the Board. 20 C.F.R. § 501.9(e). No contract for a stipulated fee or on a contingent fee basis will be approved by the Board. Id. An attorney or representative’s collection of a fee without the Board’s approval may constitute a misdemeanor, subject to fine or imprisonment for up to one year or both. Id.; see also 18 U.S.C. § 292. Demands for payment of fees to a representative, prior to approval by the Board, may be reported to appropriate authorities for investigation. 2 5 U.S.C.
    [Show full text]
  • Neck and Headache Pain
    Neck and Headache Pain ICD-9-CM code: 723.2 cervicocranial syndrome ICF codes: Activities and Participation Domain code: d4158 Maintaining a body position, other specified - specified as: maintaining the head in a flexed position, such as when reading a book; or, maintaining the head in an extended position, such as when looking up at a computer screen or video monitor Body Structure codes: s7103 Joints of head and neck region Body Functions code: b28010 Pain in head and neck Common Historical Findings: Unilateral neck pain with referral to occipital, temporal, parietal, frontal or orbital areas Headache precipitated or aggravated by neck movements or sustained positions Noncontinuous headaches (usually < 1 episode/day; < 2 episodes/week) Common Impairment Findings - Related to the Reported Activity Limitation or Participation Restrictions: Observable postural asymmetry of the head on neck (sidebent or extended) Headache reproduced with provocation of the involved segmental myofascia and/or joints O/C1, C1/C2, or C2/C3 restricted accessory motions with associated myofascial trigger points Physical Examination Procedures: Palpation/Provocation of Suboccipital Myofascia Joe Godges DPT, MA, OCS 1 KP So Cal Ortho PT Residency O/C1, C1/C2, or C2/C3 accessory motion testing using posterior-to-anterior pressures 0/C1 accessory motion testing using C1 lateral translatoty pressures C1 – C2 Rotation ROM testing with the C2 – C7 segments in flexion Joe Godges DPT, MA, OCS 2 KP So Cal Ortho PT Residency Neck and Headache Pain: Description, Etiology, Stages, and Intervention Strategies The below description is consistent with descriptions of clinical patterns associated with the term “Cervicogenic Headache.” Description: Cervicogenic headache is a headache where the source of the ache is from a structure in the cervical spine, such as a cervical facet, muscle, ligament, or dura.
    [Show full text]
  • Approach to a Case of Congenital Heart Disease
    BAI JERBAI WADIA HOSPITAL FOR CHILDREN PEDIATRIC CLINICS FOR POST GRADUATES PREFACE This book is a compilation of the discussions carried out at the course for post-graduates on ” Clinical Practical Pediatrics” at the Bai Jerbai Wadia Hospital for Children, Mumbai. It has been prepared by the teaching faculty of the course and will be a ready-reckoner for the exam-going participants. This manual covers the most commonly asked cases in Pediatric Practical examinations in our country and we hope that it will help the students in their practical examinations. An appropriately taken history, properly elicited clinical signs, logical diagnosis with the differential diagnosis and sound management principles definitely give the examiner the feeling that the candidate is fit to be a consultant of tomorrow. Wishing you all the very best for your forthcoming examinations. Dr.N.C.Joshi Dr.S.S.Prabhu Program Directors. FOREWARD I am very happy to say that the hospital has taken an initiative to organize this CME for the postgraduate students. The hospital is completing 75 years of its existence and has 2 done marvelous work in providing excellent sevices to the children belonging to the poor society of Mumbai and the country. The hospital gets cases referred from all over the country and I am proud to say that the referrals has stood the confidence imposed on the hospital and its faculty. We do get even the rarest of the rare cases which get diagnosed and treated. I am sure all of you will be immensely benefited by this programme. Wish you all the best in your examination and career.
    [Show full text]
  • Comp 3, Unit 7 Lecture a Audio Transcript
    Audio Transcript Terminology in Healthcare and Public Health Settings Endocrine System Lecture a Health IT Workforce Curriculum Version 4.0/Spring 2016 This material (Comp 3 Unit 7) was developed by the University of Alabama at Birmingham, funded by the Department of Health and Human Services, Office of the National Coordinator for Health Information Technology under Award Number 90WT00007. This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Slide 1 Welcome to Terminology in Healthcare and Public Health Settings, Endocrine System. This is lecture A, Overview of the Endocrine System, Adrenal Glands and Pancreas. In this lecture, we will be studying the endocrine system. A doctor who treats diseases of the endocrine system is called an endocrinologist. Slide 2 The objectives for the Endocrine System are to: Define, understand and correctly pronounce medical terms related to the endocrine system. Describe common diseases and conditions with an overview of various treatments related to the endocrine system. Slide 3 The endocrine system is composed of eight endocrine glands that assist in regulating our body’s activities. The endocrine glands are found in various locations throughout our body as we will see in a minute. The actions of the endocrine glands also have effects throughout the body. All endocrine glands secrete “hormones,” or chemical messengers, directly into the bloodstream where they are transported to cells that are waiting for their messages. These hormones help your body respond to stress, regulate your blood pressure, and regulate your water and salt balance.
    [Show full text]
  • Basilar Artery and Its Branches Called Pontine Arteries
    3 Farah Mohammad Ahmad Al-Tarefe Mohammad Al salem تذكر أ َّن : أولئك الذين بداخلهم شيء يفوق كل الظروف ، هم فقط من استطاعوا أ ّن يحققوا انجازاً رائعاً .... كن ذا همة Recommendation: Study this sheet after you finish the whole anatomy material . Dr.Alsalem started talking about the blood supply for brain and spinal cord which are mentioned in sheet#5 so that we didn't write them . 26:00-56:27/ Rec.Lab#3 Let start : Medulla oblengata : we will study the blood supply in two levels . A- Close medulla (central canal) : It is divided into four regions ; medial , anteromedial , posteriolateral and posterior region. Medially : anterior spinal artery. Anteromedial: vertebral artery posterolateral : posterior inferior cerebellar artery ( PICA). Posterior : posterior spinal artery which is a branch from PICA. B-Open medulla ( 4th ventricle ) : It is divided into four regions ; medial , anteromedial , posteriolateral region. Medially : anterior spinal artery. Anteromedial: vertebral artery posterolateral : posterior inferior cerebellar artery ( PICA). 1 | P a g e Lesions: 1- Medial medullary syndrome (Dejerine syndrome): It is caused by a lesion in anterior spinal artery which supplies the area close to the mid line. Symptoms: (keep your eyes on right pic). Contralateral hemiparesis= weakness: the pyramid will be affected . Contralateral loss of proprioception , fine touch and vibration (medial lemniscus). Deviation of the tongue to the ipsilateral side when it is protruded (hypoglossal root or nucleus injury). This syndrome is characterized by Alternating hemiplegia MRI from Open Medulla (notice the 4th ventricle) Note :The Alternating hemiplegia means ; 1- The upper and lower limbs are paralyzed in the contralateral side of lesion = upper motor neuron lesion .
    [Show full text]
  • RARE CHROMOSOME DISORDERS the Term, ‘Rare Chromosome Disorders’, Refers to Conditions Which
    INFORMATION SHEET Page 1 COMPLEX LEARNING DIFFICULTIES AND DISABILITIES RESEARCH PROJECT (CLDD) RARE CHROMOSOME DISORDERS The term, ‘rare chromosome disorders’, refers to conditions which: 1. occur due to missing, duplicated or re-arranged chromosome material 2. have a low prevalence rate (thus not including chromosomal disorders such as Down syndrome). Chromosomes are structures found in the nuclei of cells in human bodies. Each chromosome contains thousands of genes which determine how we grow and develop. A typically developing person will have 23 pairs of chromosomes with one member of each pair being inherited from each parent, giving a total of 46 individual chromosomes. Two of these are the sex chromosomes which determine whether we are female (XX) or male (XY). The remaining 44 chromosomes are grouped in 22 pairs, numbered 1 to 22. The arms of a chromosome are called ‘p’ (shorter arm) and ‘q’ (long arm) (see Figure 1); these arms are separated into numerical regions, which in turn are divided into bands and sub-bands. p q Figure 1. Diagram of a chromosome Individually, rare chromosome disorders are extremely uncommon, with some being actually unique; however, collectively rare chromosome disorders make up at least one in every 200 live births, with babies either having symptoms from birth or early childhood, or being carriers of a chromosomal abnormality and experiencing the effects when they try to reproduce in later life (Searle and Hultén, 2009). Recent advances in technology and medical expertise has meant that chromosomes can be viewed at ever increasing magnifications, which is resulting in the detection of more complex defects.
    [Show full text]
  • Lab 17. Chromosomes and Karyotypes: How Do Two Physically Healthy Parents Produce a Child with Down Syndrome and a Second Child
    Lab 17. Chromosomes and Karyotypes: How Do Two Physically Healthy Parents Produce a Child With Down Syndrome and a Second Child With Cri Du Chat Syndrome? Introduction Mendel’s model of inheritance is the basis for modern genetics. This important model can be broken down into four main ideas. First, and foremost, the fundamental unit of inheritance is the gene and alternative versions of a gene (alleles) account for the variation in inheritable characters. Second, an organism inherits two alleles for each character, one from each parent. Third, if the two alleles differ, then one is fully expressed and determines the nature of the specific trait (this version of the gene is called the dominant allele) while the other one has no noticeable effect (this version of the gene is called the recessive allele). Fourth, the two alleles for each character segregate (or separate) during gamete production. Therefore, an egg or a sperm cell only gets one of the two alleles that are present in the somatic cells of the organism. This idea is known as the law of segregation. It was brilliant (or lucky) that Mendel chose plant traits that turned out to have a relatively simple genetic basis. Each trait that he studied is determined by only one gene, and each of these genes only consists of two alleles. These conditions, however, are not met by all inheritable traits. The relationship between traits and genes is not always a simple one. In this investigation, you will use what you know about the relationship between traits and genes to explain how two children from the same family inherited two different genetic disorders.
    [Show full text]
  • N35.12 Postinfective Urethral Stricture, NEC, Female N35.811 Other
    N35.12 Postinfective urethral stricture, NEC, female N35.811 Other urethral stricture, male, meatal N35.812 Other urethral bulbous stricture, male N35.813 Other membranous urethral stricture, male N35.814 Other anterior urethral stricture, male, anterior N35.816 Other urethral stricture, male, overlapping sites N35.819 Other urethral stricture, male, unspecified site N35.82 Other urethral stricture, female N35.911 Unspecified urethral stricture, male, meatal N35.912 Unspecified bulbous urethral stricture, male N35.913 Unspecified membranous urethral stricture, male N35.914 Unspecified anterior urethral stricture, male N35.916 Unspecified urethral stricture, male, overlapping sites N35.919 Unspecified urethral stricture, male, unspecified site N35.92 Unspecified urethral stricture, female N36.0 Urethral fistula N36.1 Urethral diverticulum N36.2 Urethral caruncle N36.41 Hypermobility of urethra N36.42 Intrinsic sphincter deficiency (ISD) N36.43 Combined hypermobility of urethra and intrns sphincter defic N36.44 Muscular disorders of urethra N36.5 Urethral false passage N36.8 Other specified disorders of urethra N36.9 Urethral disorder, unspecified N37 Urethral disorders in diseases classified elsewhere N39.0 Urinary tract infection, site not specified N39.3 Stress incontinence (female) (male) N39.41 Urge incontinence N39.42 Incontinence without sensory awareness N39.43 Post-void dribbling N39.44 Nocturnal enuresis N39.45 Continuous leakage N39.46 Mixed incontinence N39.490 Overflow incontinence N39.491 Coital incontinence N39.492 Postural
    [Show full text]
  • Resident Scholarly Work
    RESIDENT SCHOLARLY WORK Process Improvement 2020-2021 CPIP Curriculum Ongoing Projects: Alexander Gavralidis, Stephanie tin, Matthew Macey, Allisa Alport, Beenish Furquan, Justin Byrne • Unnecessary laboratory draws in patients at a Community Hospital - evaluating whether inpatients at Salem Hospital staying overnight for a social reason undergo unnecessary laboratory draws Daria Ade, Mayuri Rapolu, Usman Mughal, Eva Kubrova, Barbara Lambl, Patrick Lee • Procalcitonin utilization to tailor antibiotic use at Salem Hospital- part of Antibiotic Stewardship program Sneha Lakshman, Arturo Castro, Ashley So, George Kavalam, Hassan Kazmi, Daniela Urma, Patrick Gordan • Development of a standardized ultrasound guided central venus catheter insertion curriculum Nupur Dandawate, Farideh Davoudi , Usama Talib, Patrick Lee • Inpatient Echo utilization – guidelines updates Anneris Estevez, Usmam Mughal, Zach Abbott, Evita Joseph, Caroline Cubbison, Faith Omede, Daniela Urma • Decrease health disparities for Hispanic community at Lynn NSPG by standardizing diabetes education referral patterns and patient education Imama Ahmad, Usama Talib, Muhammad Akash, Pablo Ledesma, Patrick Lee • Inpatient Telemetry Utilization Usman Mughal, Anneris Estevez, Patrick Lee, Barbara Lambl • Health Disparities & Covid-19 Impact on Minorities, sponsored by Dr. Patrick Lee, Chair of Medicine, Dr. Barb Lambl, Infectious Disease 2017-2020 Alexander Gavralidis, Emre Tarhan, Anneris Estevez, Daniela Urma, Austin Turner, Patrick Lee • Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19 – 5/2020 implementing use of Convalescent Plasma to MGB Salem hospital in collaboration with research team. Arturo Castro-Diaz, Dr. Daniela Urma • Improving Hospital Care and Post - acute Care of SARS CoV2 patients 4/2020- 8/2020 Caroline Cubbison, Sohaib Ansari, Adam Matos • Code Status Documentation for admitted patients at Salem Hospital - Project accepted to SHM national meeting to be presented in April 2020 Caroline Cubbison, Coleen Reid, Dr.
    [Show full text]
  • Percutaneous Conchotome Muscle Biopsy. a Useful Diagnostic and Assessment Tool CHRISTINA DORPH, INGER NENNESMO, and INGRID E
    Percutaneous Conchotome Muscle Biopsy. A Useful Diagnostic and Assessment Tool CHRISTINA DORPH, INGER NENNESMO, and INGRID E. LUNDBERG ABSTRACT. Objective. To evaluate the diagnostic yield, performance simplicity, and safety of the percutaneous conchotome muscle biopsy technique for clinical and research purposes in an outpatient rheuma- tology clinic. Methods. Biopsies taken by rheumatologists in an outpatient clinic during 1996 and 1997 were eval- uated for histopathological and clinical diagnoses. Results. A total of 149 biopsies were performed on 122 patients. Physicians learned the method easily. Samples were of adequate size and quality to allow for diagnostics. In total 106 biopsies were taken due to different diagnostic suspicions: 24 polymyositis (PM) or dermatomyositis (DM); 43 PM, DM, or vasculitis in addition to another rheumatic condition; 19 systemic vasculitis; and 20 myalgias. Criteria for definite or probable PM/DM were fulfilled in 21 patients, 18 with positive biopsies. Thirteen patients received vasculitis as clinical diagnosis, 3 with positive biopsies. No patient with myalgia had a biopsy with inflammatory changes. Fifteen of 43 rebiopsies performed to assess disease activity had signs of active inflammation. In 48% there were changes in immuno- suppressive therapy after biopsy results. Four complications occurred; one was a serious subfascial hematoma. Conclusion. The percutaneous conchotome muscle biopsy technique gives a good size sample that allows for diagnostic evaluation and has a high yield in patients with myositis. It is a simple proce- dure, easy to learn and to perform, with a low complication rate and minimum discomfort for the patient. The method can preferably be used as a diagnostic tool and to perform repeated biopsies to assess the effect of a given therapy for both clinical and research purposes.
    [Show full text]
  • Impact of Oral Vitamin C on Histamine Levels and Seasickness
    Journal of Vestibular Research 24 (2014) 281–288 281 DOI 10.3233/VES-140509 IOS Press Impact of oral vitamin C on histamine levels and seasickness R. Jarischa,∗,D.Weyerb,E.Ehlertb,C.H.Kochc,E.Pinkowskid, P. Junga,W.Kählerb, R. Girgensohne, J. Kowalskib, B. Weisserf and A. Kochb aFAZ Floridsdorf Allergy Center, Vienna, Austria bGerman Naval Medical Institute, Kronshagen, Germany cHavariekommando (Central Command for Maritime Emergencies), Cuxhaven, Germany dShip’s doctor, anesthesist in a private practice, Pohlheim, Germany eSanitätsamt der Bundeswehr (Medical Office of the German Armed Forces), Munich, Germany f Institute of Sports Science, Christian-Albrechts University, Kiel, Germany Received 3 July 2013 Accepted 17 December 2013 Abstract. BACKGROUND: Seasickness is a risk aboard a ship. Histamine is postulated as a causative agent, inversely related to the intake of vitamin C. Persons with mastocytosis experienced improvement of nausea after the intake of vitamin C. OBJECTIVE: To determine whether vitamin C suppresses nausea in 70 volunteers who spent 20 minutes in a life raft, exposed to one-meter-high waves in an indoor pool. METHOD: Double-blind placebo-controlled crossover study. Two grams of vitamin C or placebo was taken one hour before exposure. Blood samples were taken one hour before and after exposure to determine histamine, diamine oxidase, tryptase, and vitamin C levels. Symptom scores were noted on a visual analog scale. On the second day the test persons were asked which day they had felt better. RESULTS: Seven persons without symptoms were excluded from the analysis. Test persons had less severe symptoms after the intake of vitamin C (p<0.01).
    [Show full text]
  • Endocrinopathy in the Etiology of Obesity
    University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1935 Endocrinopathy in the etiology of obesity Forrest B. Spieler University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Spieler, Forrest B., "Endocrinopathy in the etiology of obesity" (1935). MD Theses. 411. https://digitalcommons.unmc.edu/mdtheses/411 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. Endocrinopathy in the Etiology of Obesity by Forrest B. Spieler Senior Thesis Uni vers! ty of Itebraska College of Medicine 1935 ,. TABLE OF CONTENTS Introduction ••••••••••••••••••••••• 1 Endoerinppathy as a Cause •••••••••• 3 Classification. • • • • • • • • • • • • . •• • • • •• 6 The pituitary types of Obesity •••••• 7 a. Froehlich's Syndrome •••••••••• 10 b. Adiposis Dolorosa ••••••••••••• 14 b. Basophilism •••••.••••.•.•••••• 2l ThyroidalObesity •••••••••••••••••• 26 AdrenalOb.slty •••••••••••••••••••• 30 GonadalObesity ••••••••••••.••.•••• 32 Pancreatic Obesity •••.••..•...••.•• 36 Conclusions •••••••••••••••••••.•••• 40 Bibliography 480728 ENDOCRINE OBESITY Introduction The movies with their Marlene Dietrichs and Jean Harlows have made the public figure-conscious. People in all walks of life, from the young coed to the elderly spinster, are doing their utmost to make their figures approximate that Of their favorite movie heroine. Even wives are at­ tempting to make the husbands'figure Jook like that of some Greek god swaggering across the silver screen.
    [Show full text]